OneAscent Financial Services LLC Acquires 276 Shares of Mettler-Toledo International, Inc. (NYSE:MTD)

OneAscent Financial Services LLC increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 158.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 450 shares of the medical instruments supplier's stock after acquiring an additional 276 shares during the quarter. OneAscent Financial Services LLC's holdings in Mettler-Toledo International were worth $526,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in MTD. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 9.9% in the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock valued at $713,627,000 after buying an additional 52,726 shares in the last quarter. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after buying an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Mettler-Toledo International by 6.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock valued at $557,680,000 after acquiring an additional 25,873 shares during the period. GAMMA Investing LLC lifted its position in shares of Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after acquiring an additional 385,864 shares during the period. Finally, T. Rowe Price Investment Management Inc. lifted its position in shares of Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after acquiring an additional 96,300 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Barclays started coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Evercore ISI upped their price objective on Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 8th. Finally, Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $1,280.90.

Mettler-Toledo International Trading Up 0.2%

NYSE MTD traded up $2.00 during trading hours on Thursday, hitting $1,259.20. 112,962 shares of the company's stock were exchanged, compared to its average volume of 174,764. The stock has a 50-day simple moving average of $1,179.25 and a 200 day simple moving average of $1,193.87. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93. The firm has a market cap of $26.17 billion, a price-to-earnings ratio of 31.44, a PEG ratio of 3.75 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The business had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same quarter last year, the firm posted $8.89 earnings per share. The firm's revenue was down 4.6% on a year-over-year basis. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director owned 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.